peripheral arterial disease: A disorder of the arteries supplying the upper and lower extremity and the visceral organs. This includes the mesenteric arteries, the renal arteries and the aorta and excludes cerebrovascular arterial disease. Patients experience cramping and pain usually in the calves and thighs while walking. The symptoms subside with rest.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3234 |
4. Check minimum number of eventsNone |
3234 |
5. Include endpoints |
3234 |
6. Filter based on genotype QC (FinnGen only) |
3234 |
Control definitions (FinnGen only)
- Control exclude
- I9_DOAAC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I70-I79
- Name in latin
- Alii morbi vasorum periphericorum
Similar endpoints
↥List of similar endpoints to
Other peripheral vascular diseases
based on the number of shared cases.
Similar with more cases:
- Diseases of arteries, arterioles and capillaries
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 22570 | 12619 | 9640 |
| Only index persons | 17684 | 11139 | 6545 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.32 | 0.36 | 0.27 |
| Only index persons | 0.35 | 0.41 | 0.25 |
| Median age at first event (years) | |||
| Whole population | 50.54 | 45.53 | 56.80 |
| Only index persons | 47.80 | 43.90 | 54.43 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3234 | 2049 | 1185 |
| Unadjusted period prevalence (%) | 0.63 | 0.70 | 0.52 |
| Median age at first event (years) | 49.80 | 45.29 | 57.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2870
- Matched controls
- 28700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C08CA05
ATC
nifedipine; systemic
13.3
323.0
791
798
I73.0
ICD-10 Finland
Raynaud syndrome
850.1
323.0
1672
47
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
90.5
323.0
591
82
I73.9
ICD-10 Finland
Peripheral vascular disease, unspecified
668.1
323.0
545
10
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
16.4
299.3
503
367
44300
ICD-8 Finland
Other peripheral vascular disease, Raynaud's syndrome
+∞
195.0
185
*
I73.8
ICD-10 Finland
Other specified peripheral vascular diseases
378.3
179.6
179
5
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
22.6
143.6
212
101
XPX04
NOMESCO Finland
Angioscopy
64.5
126.5
147
24
XX9XE
NOMESCO Finland
Other ultrasound examination
23.9
115.4
167
74
P01BA02
ATC
hydroxychloroquine; oral
4.3
110.3
456
1209
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
158.7
101.9
107
7
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
122.2
98.7
106
9
M34.1
ICD-10 Finland
CR(E)ST syndrome
42.8
95.3
119
29
I73.1
ICD-10 Finland
Thromboangiitis obliterans [Buerger]
863.5
86.1
84
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
81.8
474
1638
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
81.1
1302
7941
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
62.6
78.1
91
15
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.9
72.8
323
896
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
+∞
71.1
68
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.5
70.8
364
1141
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
242.5
69.6
71
*
44390
ICD-8 Finland
Other peripheral vascular disease, Claudicatio intermittens
+∞
69.0
66
*
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
147.6
68.2
72
5
NHQ40
NOMESCO Finland
Amputation of toe
+∞
68.0
65
*
4430A
ICD-9 Finland
Other peripheral vascular disease, Raynaud's syndrome
+∞
65.9
63
*
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
+∞
64.8
62
*
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
80.9
63.3
71
9
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
135.0
62.1
66
5
C08CA02
ATC
felodipine; oral
3.2
61.4
357
1220
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
160.9
60.1
63
*
PE1AT
NOMESCO Finland
Femoral artery PTA
600.3
59.9
59
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
49.7
56.3
68
14
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
558.6
55.8
55
*
M25.5
ICD-10 Finland
Pain in joint
2.0
53.9
860
5002
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
7.0
52.2
133
197
B01AC04
ATC
clopidogrel; oral
2.5
51.5
448
1955
N02AX02
ATC
tramadol; systemic, rectal
1.9
51.2
1207
8070
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
20.3
51.1
77
39
N03AX16
ATC
pregabalin; oral
2.0
48.1
710
3967
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
39.5
46.1
58
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
44.9
837
5094
N03AX12
ATC
gabapentin; oral
2.2
44.7
497
2445
H02AB06
ATC
prednisolone; systemic
1.8
44.7
1325
9406
44020
ICD-8 Finland
Arteriosclerosis, Of arteries of the extremities
+∞
43.9
42
*
44308
ICD-8 Finland
NA
+∞
42.8
41
*
44301
ICD-8 Finland
NA
+∞
42.8
41
*
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
+∞
42.8
41
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.1
41.6
582
3154
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.9
41.5
178
474
M79.6
ICD-10 Finland
Pain in limb
1.8
40.8
988
6523
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.4
40.0
153
366
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.0
39.8
113
194
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
39.8
315
1296
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
+∞
39.7
38
*
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
+∞
39.7
38
*
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
37.5
37.8
48
13
NFQ20
NOMESCO Finland
Amputation of femur
83.2
36.9
41
5
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
+∞
35.5
34
*
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
+∞
35.5
34
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.9
34.0
145
384
44310
ICD-8 Finland
Other peripheral vascular disease, Thrombo-angiitis obliterans (Buerger's disease)
+∞
33.4
32
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.9
32.8
111
235
Z57.7
ICD-10 Finland
Occupational exposure to vibration
+∞
32.3
31
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
31.7
607
3653
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
48.1
31.6
38
8
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
31.5
553
3228
PD3AT
NOMESCO Finland
Pelvic artery PTA
+∞
31.3
30
*
C08CA01
ATC
amlodipine; oral
1.7
31.3
903
6165
J01FF01
ATC
clindamycin; systemic
1.7
31.1
731
4695
M35.1
ICD-10 Finland
Other overlap syndromes
15.6
29.9
49
32
44399
ICD-8 Finland
Other peripheral vascular disease, Unspecified
+∞
29.2
28
*
L04AX01
ATC
azathioprine; systemic
3.3
29.0
152
477
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
28.3
590
3635
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.9
28.1
465
2648
A02BC02
ATC
pantoprazole; systemic
1.5
27.5
1709
13998
B01AC07
ATC
dipyridamole; systemic
3.1
27.4
155
513
M34.0
ICD-10 Finland
Progressive systemic sclerosis
53.9
27.2
32
6
C01DA14
ATC
isosorbide mononitrate; oral
2.0
27.0
408
2243
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
26.9
515
3079
PEN23
NOMESCO Finland
Plastic repair of femoral artery
75.9
26.8
30
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
26.3
529
3212
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
29.5
26.3
35
12
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
26.2
242
1075
4439X
ICD-9 Finland
Other peripheral vascular disease, Peripheral vascular disease, unspecified
+∞
26.1
25
*
C03CA01
ATC
furosemide; systemic
1.7
25.8
720
4822
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
25.7
279
1338
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
25.6
269
1271
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
25.4
683
4522
E0000UV
ATC
NA
1.6
25.2
1037
7656
R06.0
ICD-10 Finland
Dyspnoea
1.7
25.2
648
4237
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.5
25.1
121
357
I72.4
ICD-10 Finland
Aneurysm and dissection of artery of lower extremity
+∞
25.0
24
*
I70.0
ICD-10 Finland
Atherosclerosis of aorta
252.3
24.7
25
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
24.6
276
1344
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
24.3
426
2467
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
24.1
530
3301
NGQ20
NOMESCO Finland
Amputation of lower leg
+∞
24.0
23
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
23.9
851
6051
UJF32
NOMESCO Finland
Coloscopy
1.6
23.8
669
4469
L04AA06
ATC
mycophenolic acid; systemic
5.6
23.5
69
125
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.3
23.3
88
210
L17
ICPC
Foot/toe symptom/complaint
1.6
23.1
637
4231
I74.2
ICD-10 Finland
Embolism and thrombosis of arteries of upper extremities
+∞
22.9
22
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.7
22.4
100
277
TEA00
NOMESCO Finland
Biopsy of lip
8.1
22.2
50
63
M48.0
ICD-10 Finland
Spinal stenosis
2.0
22.0
323
1750
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.7
22.0
154
586
T75.2
ICD-10 Finland
Effects of vibration
+∞
21.9
21
*
ZPB22
NOMESCO Finland
Autograft of vein
80.7
21.7
24
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.5
21.6
47
56
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
21.4
258
1294
J01DA01
ATC
[U] cefalexin; systemic
1.5
21.2
1676
14055
4431A
ICD-9 Finland
Other peripheral vascular disease, Thromboangiitis obliterans [Buerger's disease]
+∞
20.9
20
*
44302
ICD-8 Finland
NA
+∞
20.9
20
*
XPX08
NOMESCO Finland
Intraoperative flow measurement
14.2
20.8
35
25
Z3226
NOMESCO Finland
Physiotherapist
1.7
20.1
463
2910
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
20.0
369
2164
C02KX01
ATC
bosentan; oral
57.9
19.9
23
*
A02BC03
ATC
lansoprazole; oral
1.5
19.8
768
5523
PGH47
NOMESCO Finland
Bypass from femoral to contralateral femoral artery
+∞
19.8
19
*
PEP25
NOMESCO Finland
Percutaneous plastic repair of superficial femoral artery
+∞
19.8
19
*
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
+∞
19.8
19
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
19.8
239
1198
SBA10
NOMESCO Finland
Measurement of excretion of saliva
6.4
19.7
52
83
S97
ICPC
Chronic ulcer skin
2.8
19.5
132
494
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
5.4
19.5
59
112
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
19.3
402
2449
N06AA09
ATC
amitriptyline; systemic
1.9
19.3
283
1531
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.2
19.2
196
913
C02DE02
ATC
NA
4.9
19.1
63
132
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
19.1
271
1450
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
19.0
197
923
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
19.0
317
1796
M54.2
ICD-10 Finland
Cervicalgia
2.3
18.9
187
857
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
18.9
281
1529
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
18.8
419
2605
PDH54
NOMESCO Finland
Bypass from aorta to bilateral femoral arteries
+∞
18.8
18
*
R50.9
ICD-10 Finland
Fever, unspecified
1.8
18.5
351
2076
AN1
HP
Coronary angiography
1.9
18.4
283
1557
A02BC01
ATC
omeprazole; systemic
1.5
18.3
717
5153
A02BC05
ATC
esomeprazole; systemic
1.5
18.2
1025
7944
PD4DG
NOMESCO Finland
Very extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
44.3
18.2
22
5
N06AX21
ATC
duloxetine; oral
1.9
18.2
290
1616
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
18.1
1135
8986
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
18.0
901
6820
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
18.0
192
910
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
18.0
266
1443
E000001
ATC
NA
1.6
17.9
536
3606
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
17.9
217
1090
44388
ICD-8 Finland
Other peripheral vascular disease, Other
+∞
17.7
17
*
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
+∞
17.7
17
*
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
+∞
17.7
17
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
17.6
312
1803
ZPB40
NOMESCO Finland
Polytetrafluoroethylene
181.0
17.5
18
*
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
181.0
17.5
18
*
2424
FHL
Sympatectomy, lumbar
181.0
17.5
18
*
R51.80
ICD-10 Finland
Headache
1.7
17.4
382
2359
I50.0
ICD-10 Finland
Congestive heart failure
2.2
17.3
176
818
AA1AD
NOMESCO Finland
CT of head and brain
1.6
17.2
570
3929
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
12.6
17.1
30
24
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
17.1
162
729
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
17.0
325
1923
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.8
16.8
331
1978
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
16.8
275
1545
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
16.7
161
728
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
+∞
16.7
16
*
5565
FHL
Femoropopliteal bypass surgery
+∞
16.7
16
*
N05CF01
ATC
zopiclone; oral
1.5
16.6
812
6096
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
16.6
304
1776
I25.2
ICD-10 Finland
Old myocardial infarction
2.2
16.4
164
755
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
16.4
326
1956
L12
ICPC
Hand/finger symptom/complaint
1.7
16.2
357
2204
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
16.1
228
1217
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
16.0
939
7290
J01MA02
ATC
ciprofloxacin; systemic
1.4
16.0
953
7422
Z3231
NOMESCO Finland
Registered nurse
1.5
15.9
657
4750
R4120
NOMESCO Finland
Occupational therapy
2.2
15.9
166
781
R03BB04
ATC
tiotropium bromide; inhalant
1.9
15.7
248
1379
M54.5
ICD-10 Finland
Low back pain
1.4
15.7
806
6096
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
+∞
15.6
15
*
PDG51
NOMESCO Finland
Bypass from aorta to iliac artery for aneurysm
+∞
15.6
15
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
85.5
15.6
17
*
315
Kela drug reimbursment
Clopidogrel
5.6
15.5
45
82
C08DB01
ATC
diltiazem; oral
2.3
15.5
145
646
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
15.4
179
884
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
38.3
15.4
19
5
J01DB01
ATC
cefalexin; oral
1.4
15.4
2147
19375
J01MA12
ATC
levofloxacin; systemic
1.6
15.0
438
2918
G54.0
ICD-10 Finland
Brachial plexus disorders
3.2
15.0
79
252
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.3
14.9
136
601
N02BE01
ATC
paracetamol; systemic, rectal
1.5
14.9
2279
20842
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
57.0
14.8
17
*
R03AC02
ATC
salbutamol; inhalant
1.4
14.6
1313
10939
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
14.6
323
1997
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
14.6
194
1011
H02AB07
ATC
prednisone; oral
1.7
14.5
356
2266
PD4AD
NOMESCO Finland
CT of lower extremity arteries
150.7
14.5
15
*
PD4HE
NOMESCO Finland
Postoperative lower extremity artery ultrasound examination with Doppler method
150.7
14.5
15
*
2423
FHL
Sympatectomy, thoracic
150.7
14.5
15
*
D07AC01
ATC
betamethasone; topical
1.4
14.4
821
6316
M03BX02
ATC
tizanidine; oral
1.4
14.3
1541
13203
ADA20
NOMESCO Finland
Thoracal sympathectomy
27.3
14.3
19
7
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
14.3
1037
8326
XF402
NOMESCO Finland
ECG with work load test
1.8
14.0
257
1498
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
7.5
13.9
32
43
C07AB07
ATC
bisoprolol; oral
1.4
13.9
1098
8929
ZXA00
NOMESCO Finland
Right side
1.5
13.8
639
4713
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
13.7
242
1392
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
13.6
13.7
23
17
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
13.6
418
2821
PDG05
NOMESCO Finland
Operation on infrarenal abdominal aorta for aneurysm
+∞
13.5
13
*
PEN24
NOMESCO Finland
Plastic repair of deep femoral artery
+∞
13.5
13
*
PEN25
NOMESCO Finland
Plastic repair of superficial femoral artery
+∞
13.5
13
*
I71.3
ICD-10 Finland
Abdominal aortic aneurysm, ruptured
+∞
13.5
13
*
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
+∞
13.5
13
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
13.5
669
5000
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.0
13.4
169
864
R60.0
ICD-10 Finland
Localized oedema
1.8
13.4
260
1542
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
13.4
394
2627
S18
ICPC
Laceration/cut
1.4
13.4
982
7879
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
4.1
13.3
51
126
XG410
NOMESCO Finland
Flow-volume spirometry
2.3
13.3
118
517
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
13.2
180
947
R42
ICD-10 Finland
Dizziness and giddiness
1.5
13.1
526
3764
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
12.9
240
1409
G44.2
ICD-10 Finland
Tension-type headache
1.6
12.9
329
2115
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
6.9
12.8
31
45
Z2221
NOMESCO Finland
Medical doctor
1.4
12.8
674
5085
M05BA04
ATC
alendronic acid; oral
1.9
12.7
199
1099
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
12.7
420
2875
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
12.7
186
1006
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.5
12.7
102
425
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
12.7
238
1398
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
12.7
366
2428
ZXD05
NOMESCO Finland
Urgent procedure
1.4
12.6
745
5738
I70
ICD-10 Finland
Atherosclerosis
15.5
12.6
20
13
XPX00
NOMESCO Finland
Intraoperative angiography
70.2
12.6
14
*
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
12.5
170
893
ZX120
NOMESCO Finland
Intravenous
1.8
12.5
223
1289
PDP20
NOMESCO Finland
Percutaneous plastic repair of common iliac artery
+∞
12.5
12
*
PFH63
NOMESCO Finland
Bypass from femoral or popliteal artery to distal posterior tibial artery
+∞
12.5
12
*
I73
ICD-10 Finland
Other peripheral vascular diseases
+∞
12.5
12
*
PDQ20
NOMESCO Finland
Insertion of endovascular graft into common iliac artery
+∞
12.5
12
*
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
+∞
12.5
12
*
I72.0
ICD-10 Finland
Aneurysm and dissection of carotid artery
+∞
12.5
12
*
A02BA02
ATC
ranitidine; systemic
1.5
12.5
493
3509
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
12.5
629
4709
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.4
12.4
103
436
J02AC01
ATC
fluconazole; systemic
1.4
12.4
1022
8325
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.2
12.4
65
209
K59.0
ICD-10 Finland
Constipation
2.0
12.3
150
756
NDQ20
NOMESCO Finland
Amputation of finger
10.5
12.2
23
22
PD5BD
NOMESCO Finland
Extensive CT of aorta
4.5
12.2
42
94
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
37.7
12.2
15
*
R4110
NOMESCO Finland
Physiotherapy
1.4
12.1
603
4498
K74.3
ICD-10 Finland
Primary biliary cirrhosis
6.1
12.1
32
53
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.0
12.1
69
233
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
12.1
197
1105
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
12.0
129
618
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
11.9
255
1558
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
11.9
155
803
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.5
11.8
94
390
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.5
11.8
93
383
N06AX11
ATC
mirtazapine; oral
1.4
11.8
754
5880
M01AH02
ATC
rofecoxib; oral
1.6
11.8
318
2072
J01FA10
ATC
azithromycin; systemic
1.3
11.6
1420
12240
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.3
11.6
57
175
L88
ICPC
Rheumatoid/seropositive arthritis
2.3
11.6
101
440
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.8
11.5
72
259
9571
FHL
Amputation of toe or toes
+∞
11.5
11
*
K55.1
ICD-10 Finland
Chronic vascular disorders of intestine
+∞
11.5
11
*
I74.9
ICD-10 Finland
Embolism and thrombosis of unspecified artery
120.5
11.4
12
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.7
11.4
48
130
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
11.4
211
1234
A46
ICD-10 Finland
Erysipelas
1.6
11.2
297
1923
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
11.2
430
3037
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
11.1
163
882
ZXA10
NOMESCO Finland
Bilateral
1.5
11.1
432
3063
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
11.1
147
769
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.8
10.9
45
120
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
10.9
109
505
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.5
10.9
81
325
M01AH05
ATC
etoricoxib; oral
1.3
10.9
1418
12284
M79.1
ICD-10 Finland
Myalgia
1.6
10.7
292
1905
PG1UT
NOMESCO Finland
Percutaneous aspiration throbectomy
28.1
10.7
14
5
C10AX09
ATC
ezetimibe; oral
1.7
10.7
222
1346
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
10.7
178
1006
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.5
10.7
48
138
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
10.6
408
2880
R13
ICD-10 Finland
Dysphagia
1.9
10.6
147
779
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
10.6
286
1860
I78.9
ICD-10 Finland
Disease of capillaries, unspecified
60.2
10.6
12
*
L84
ICD-10 Finland
Corns and callosities
2.5
10.6
82
336
B01AA03
ATC
warfarin; systemic
1.5
10.6
440
3163
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
10.6
96
425
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.8
10.5
66
239
280
Kela drug reimbursment
Clopidogrel
3.9
10.5
42
110
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
10.4
183
1052
PDP22
NOMESCO Finland
Percutaneous plastic repair of a. iliaca externa
+∞
10.4
10
*
I70.1
ICD-10 Finland
Atherosclerosis of renal artery
+∞
10.4
10
*
NGQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of knee or lower leg
+∞
10.4
10
*
XP60W
NOMESCO Finland
NA
+∞
10.4
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
10.4
174
986
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.0
10.4
133
685
F50.0
ICD-10 Finland
Anorexia nervosa
5.9
10.4
28
48
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.1
10.4
54
174
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
10.4
145
773
ZXE00
NOMESCO Finland
One hour or less
1.3
10.3
941
7729
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
10.3
510
3785
C07AG02
ATC
carvedilol; oral
2.0
10.3
137
717
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
10.3
212
1283
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
32.6
10.3
13
*
I70.8
ICD-10 Finland
Atherosclerosis of other arteries
32.6
10.3
13
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
10.3
657
5102
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
10.3
538
4037
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
10.3
164
916
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
23.4
10.2
14
6
XF404
NOMESCO Finland
Ambulatory ECG
1.7
10.2
202
1209
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
10.1
328
2229
81
HP
Angiography of the heart and coronary arteries
1.9
10.1
143
765
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.2
10.1
101
471
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
5.5
9.9
28
51
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.0
9.9
117
585
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
9.9
662
5175
M79.7
ICD-10 Finland
Fibromyalgia
2.3
9.9
86
374
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.7
9.9
225
1400
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
26.1
9.8
13
5
M01AB05
ATC
diclofenac; systemic, rectal
1.3
9.8
1638
14585
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
8.7
9.8
20
23
M01AC06
ATC
meloxicam; systemic, rectal
1.3
9.7
855
6971
WX892
NOMESCO Finland
Monitored bed care
1.8
9.7
159
897
R55
ICD-10 Finland
Syncope and collapse
1.6
9.7
246
1578
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
9.7
365
2565
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
9.7
569
4354
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
9.6
141
763
XPX16
NOMESCO Finland
Ultrasound investigation of periferal vessel
55.2
9.6
11
*
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.4
9.6
44
129
I20.00
ICD-10 Finland
Unstable angina
2.5
9.6
73
298
ZXA05
NOMESCO Finland
Left side
1.4
9.5
577
4435
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
10.1
9.5
18
18
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.5
853
6976
J01AA02
ATC
doxycycline; systemic
1.3
9.4
2005
18374
L14
ICPC
Leg/thigh symptom/complaint
1.8
9.4
162
929
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
100.3
9.4
10
*
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.0
9.4
36
91
RT160
NOMESCO Finland
NA
30.1
9.4
12
*
PEU99
NOMESCO Finland
Other repair after previous reconstruction of femoral artery with branches and connection to popliteal artery
+∞
9.4
9
*
PD4ST
NOMESCO Finland
Endovascular thrombolysis of pelvic and lower extremity arteries
+∞
9.4
9
*
ZPB20
NOMESCO Finland
Vene in its own postion
+∞
9.4
9
*
I72.1
ICD-10 Finland
Aneurysm and dissection of artery of upper extremity
+∞
9.4
9
*
PFH66
NOMESCO Finland
Bypass from femoral or popliteal artery to dorsal artery of foot
+∞
9.4
9
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.1
9.4
50
165
R52.2
ICD-10 Finland
Other chronic pain
2.3
9.3
85
377
N02AA05
ATC
oxycodone; systemic
1.5
9.3
316
2171
C10AA05
ATC
atorvastatin; oral
1.3
9.3
808
6565
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.8
9.3
59
217
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
9.2
151
851
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
9.2
898
7419
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
9.2
207
1284
C03DA01
ATC
spironolactone; oral
1.6
9.1
218
1376
R07.3
ICD-10 Finland
Other chest pain
1.6
9.1
210
1313
K07.60
ICD-10 Finland
Snapping jaw
2.0
9.1
119
621
I50.1
ICD-10 Finland
Left ventricular failure
2.1
9.0
96
459
4120X
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
3.5
9.0
41
120
A04
ICPC
Weakness/tiredness general
1.5
9.0
285
1927
M35.7
ICD-10 Finland
Hypermobility syndrome
3.3
9.0
43
131
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
9.0
158
911
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
2.5
9.0
68
275
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
9.0
271
1813
3007
Kela drug reimbursment
Erenumab and fremanezumab
3.8
8.9
36
96
L03
ICPC
Low back symptom/complaint
1.4
8.8
548
4224
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.6
8.8
64
254
I20.09
ICD-10 Finland
Unstable angina
1.9
8.8
122
649
A03FA02
ATC
cisapride; oral, rectal
1.7
8.8
192
1186
D68.8
ICD-10 Finland
Other specified coagulation defects
4.0
8.7
33
83
M54.6
ICD-10 Finland
Pain in thoracic spine
1.8
8.7
147
839
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
8.7
274
1850
UJF92
NOMESCO Finland
Capsular endoscopy
2.9
8.7
50
173
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
8.6
257
1712
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
8.6
214
1367
WX213
NOMESCO Finland
Lower leg blockade
8.2
8.6
18
22
L08
ICPC
Shoulder symptom/complaint
1.4
8.5
410
3022
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.5
354
2539
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
3.1
8.5
44
143
C09CA06
ATC
candesartan; oral
1.4
8.5
465
3511
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
90.3
8.4
9
*
PWC00
NOMESCO Finland
Reoperation for deep infection in surgery of peripheral vessels and lymphatic system
90.3
8.4
9
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.4
8.4
68
287
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
8.4
1195
10341
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
2.1
8.4
92
449
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.1
8.4
91
439
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
6.7
8.3
20
30
4409X
ICD-9 Finland
Atherosclerosis, Generalised and unspecified atherosclerosis
+∞
8.3
8
*
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
+∞
8.3
8
*
PDQ22
NOMESCO Finland
Insertion of endovascular graft into a. iliaca externa
+∞
8.3
8
*
PFH62
NOMESCO Finland
Bypass from femoral or popliteal artery to proximal posterior tibial artery
+∞
8.3
8
*
PEU81
NOMESCO Finland
Thrombectomy or embolectomy of bypass from femoral to popliteal artery
+∞
8.3
8
*
PD3BT
NOMESCO Finland
Pelvic artery extensive PTA
+∞
8.3
8
*
I702, L97
ICD-10 Finland
NA
+∞
8.3
8
*
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.8
8.3
152
888
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.0
8.3
102
519
R06AX27
ATC
desloratadine; oral
1.3
8.3
614
4860
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
8.3
118
634
A11
ICPC
Chest pain NOS
1.7
8.3
169
1024
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
8.3
538
4178
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
8.2
620
4920
R52.9
ICD-10 Finland
Pain, unspecified
1.6
8.2
191
1197
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
8.2
655
5247
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.3
8.2
72
316
WX002
NOMESCO Finland
Sedation and analgesia
1.4
8.2
429
3213
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
2.2
8.2
83
392
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
8.1
105
545
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.0
8.1
105
545
XA402
NOMESCO Finland
ENMG
2.4
8.1
66
280
PD1AE
NOMESCO Finland
Ultrasound examination of abdominal aortta
17.2
8.1
12
7
L04
ICPC
Chest symptom/complaint
1.8
8.0
122
673
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
8.0
408
3041
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
5.5
8.0
22
40
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.8
8.0
49
179
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
7.9
99
508
G43.3
ICD-10 Finland
Complicated migraine
2.9
7.9
46
162
R06AE07
ATC
cetirizine; oral
1.3
7.9
1028
8783
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
7.8
189
1197
R05
ICPC
Cough
1.4
7.8
496
3835
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.9
7.7
112
608
ZZA00
NOMESCO Finland
Split skin graft
2.4
7.7
63
266
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
45.1
7.7
9
*
I78.8
ICD-10 Finland
Other diseases of capillaries
45.1
7.7
9
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
4.2
7.7
27
64
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
7.7
119
659
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.0
7.7
89
445
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
5.3
7.7
22
42
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.2
7.7
77
362
N02CD01
ATC
erenumab; parenteral
3.8
7.6
30
79
J01EA01
ATC
trimethoprim; systemic
1.3
7.6
617
4946
K84
ICPC
Heart disease other
2.5
7.6
56
224
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.2
7.6
74
343
XQ800
NOMESCO Finland
Prick test
1.7
7.6
164
1006
N07BA03
ATC
varenicline; oral
1.9
7.6
101
532
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
7.6
57
233
RJ521
NOMESCO Finland
NA
18.4
7.6
11
6
N04BC05
ATC
pramipexole; oral
1.7
7.6
164
1009
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
7.6
124
701
TAD02
NOMESCO Finland
Sympathetic block of ganglion stellatum
11.9
7.6
13
11
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
25.1
7.6
10
*
S29
ICPC
Skin symptom/complaint other
1.4
7.6
363
2673
M54.1
ICD-10 Finland
Radiculopathy
2.0
7.5
86
428
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.3
7.5
35
106
J01CA04
ATC
amoxicillin; systemic
1.3
7.5
2040
18941
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.5
7.5
237
1602
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.9
7.5
104
557
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
7.5
119
667
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.4
898
7588
PG1ST
NOMESCO Finland
Endovascular arterial thrombolysis with radiological guidance not elsewhere classified
80.3
7.4
8
*
PEE23
NOMESCO Finland
Thrombectomy or embolectomy of femoral artery
80.3
7.4
8
*
C10AA01
ATC
simvastatin; oral
1.3
7.4
943
8018
A02BA03
ATC
famotidine; systemic
2.0
7.4
93
479
M01AX17
ATC
nimesulide; oral
1.3
7.4
568
4513
L28
ICPC
Limited function/disability (L)
1.4
7.4
334
2434
M54.3
ICD-10 Finland
Sciatica
1.8
7.4
124
709
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.3
7.3
34
103
PG1DM
NOMESCO Finland
Very extensive MRI examination of vasculature not elsewhere classified with 3 Tesla magnet
+∞
7.3
7
*
PFH65
NOMESCO Finland
Bypass from femoral or popliteal artery to distal peroneal artery
+∞
7.3
7
*
PFH58
NOMESCO Finland
Bypass from femoral or popliteal artery to proximal anterior tibial artery
+∞
7.3
7
*
I77.9
ICD-10 Finland
Disorder of arteries and arterioles, unspecified
+∞
7.3
7
*
ADA30
NOMESCO Finland
Lumbal sympathectomy
+∞
7.3
7
*
4438X
ICD-9 Finland
Other peripheral vascular disease, Other specified peripheral vascular diseases
+∞
7.3
7
*
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
7.3
7
*
I71.01
ICD-10 Finland
Aneurysm of the descending aorta
+∞
7.3
7
*
WX872
NOMESCO Finland
Intensive care
2.0
7.3
92
475
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
7.3
218
1456
82
HP
Single vessel balloon catheter extension
2.5
7.2
54
219
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.2
921
7825
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
7.2
102
549
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
7.2
76
365
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
7.2
279
1971
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
7.2
305
2194
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.7
7.2
47
178
SPAT1263
SPAT
Sampling
1.3
7.2
1016
8738
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.7
7.2
128
746
J01DA06
ATC
[U] cefuroxime; systemic
1.4
7.1
324
2362
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.8
7.1
127
737
M25.2
ICD-10 Finland
Flail joint
3.4
7.1
32
95
H02AB09
ATC
hydrocortisone; systemic
2.4
7.1
54
224
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.5
7.1
220
1483
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
5.6
7.1
19
34
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.9
7.0
94
495
C07AB02
ATC
metoprolol; systemic
1.3
7.0
452
3499
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
7.0
372
2789
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.0
918
7824
M10.9
ICD-10 Finland
Gout, unspecified
1.7
7.0
126
737
G62.8
ICD-10 Finland
Other specified polyneuropathies
4.1
7.0
25
61
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
7.0
81
406
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
2.7
6.9
43
159
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
6.9
103
564
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
6.9
305
2210
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.8
6.9
116
661
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
6.9
144
879
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.6
6.9
48
187
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
6.9
107
598
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.4
6.8
52
215
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.8
520
4128
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
6.8
150
929
SPAT1211
SPAT
Application of soft bandage
1.6
6.8
192
1265
N03AF01
ATC
carbamazepine; oral, rectal
1.8
6.8
119
690
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.2
6.8
68
320
L29
ICPC
Musculoskeletal sympt/complt other
1.6
6.8
161
1018
NH3CG
NOMESCO Finland
Extensive MRI of foot
5.0
6.8
20
40
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.8
6.8
110
624
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
40.1
6.8
8
*
R76.0
ICD-10 Finland
Raised antibody titre
5.7
6.7
18
32
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
2.1
6.7
73
357
XQ848
NOMESCO Finland
Dermatological photography
2.3
6.7
57
248
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
6.7
52
218
R03AC19
ATC
olodaterol; inhalant
7.2
6.7
15
21
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.1
6.7
34
111
K30
ICD-10 Finland
Functional dyspepsia
1.5
6.7
223
1529
D06BX01
ATC
metronidazole; topical
1.5
6.7
230
1586
V03AX01
ATC
[D]nalfurafine; oral
3.6
6.7
28
79
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.6
6.6
45
176
R04.2
ICD-10 Finland
Haemoptysis
2.1
6.6
74
365
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.1
6.6
69
329
R02
ICPC
Shortness of breath/dyspnoea
1.5
6.6
248
1743
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
6.6
151
945
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
7.8
6.6
14
18
M77.4
ICD-10 Finland
Metatarsalgia
1.8
6.6
117
680
TGC00
NOMESCO Finland
Bronchial lavation
2.3
6.6
54
233
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
4.6
6.6
21
46
RJ414
NOMESCO Finland
NA
12.3
6.6
11
9
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.7
6.6
129
774
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
6.6
157
995
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.7
6.6
122
720
L01
ICPC
Neck symptom/complaint
1.4
6.6
299
2184
Z2446
NOMESCO Finland
Social worker
1.7
6.5
134
815
SPAT1097
SPAT
Recording of ECG
1.4
6.5
321
2372
78739
ICD-8 Finland
Symptoms referable to limbs and joints, Arthralgia alia sive NUD
4.8
6.5
20
42
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.8
6.5
109
625
K92
ICPC
Atherosclerosis/periph vascular dis
4.0
6.5
24
61
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.1
6.4
32
103
I77.6
ICD-10 Finland
Arteritis, unspecified
70.0
6.4
7
*
I77.8
ICD-10 Finland
Other specified disorders of arteries and arterioles
70.0
6.4
7
*
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
3.4
6.4
29
87
L99
ICPC
Musculoskeletal disease other
2.4
6.4
49
203
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
6.4
234
1635
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
6.4
108
618
PWW99
NOMESCO Finland
Other reoperation on peripheral vessels or lymphatic system
14.3
6.4
10
7
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.0
6.4
34
115
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.0
6.4
75
380
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
3.5
6.4
27
77
L04AD01
ATC
ciclosporin; systemic
2.5
6.4
47
193
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
6.3
132
808
J38.7
ICD-10 Finland
Other diseases of larynx
5.2
6.3
18
35
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
6.3
167
1088
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.6
6.3
151
957
RJ410
NOMESCO Finland
NA
5.5
6.3
17
31
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
9.3
6.3
12
13
R68.2
ICD-10 Finland
Dry mouth, unspecified
4.6
6.3
20
44
R02
ICD-10 Finland
Gangrene, not elsewhere classified
18.0
6.3
9
5
PD7ZT
NOMESCO Finland
Stent grafting of abdominal aorta
+∞
6.2
6
*
PFP26
NOMESCO Finland
Percutaneous plastic repair of popliteal artery
+∞
6.2
6
*
9573
FHL
Leg amputation
+∞
6.2
6
*
PFA26
NOMESCO Finland
Exploration of popliteal artery
+∞
6.2
6
*
I74.8
ICD-10 Finland
Embolism and thrombosis of other arteries
+∞
6.2
6
*
5562
FHL
Reconstruction of the aortoil cabbage area
+∞
6.2
6
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.8
6.2
103
586
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.7
6.2
38
140
Z01.2
ICD-10 Finland
Dental examination
1.2
6.2
925
7973
K01
ICPC
Heart pain
3.2
6.2
30
95
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
6.2
75
381
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
6.2
172
1133
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.9
6.2
90
493
N02CD03
ATC
fremanezumab; systemic
4.1
6.2
22
54
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
6.2
179
1190
F50.1
ICD-10 Finland
Atypical anorexia nervosa
5.0
6.2
18
36
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.6
6.2
145
916
D01BA02
ATC
terbinafine; oral; topical
1.3
6.2
524
4219
RJ420
NOMESCO Finland
NA
6.3
6.2
15
24
GD1AD
NOMESCO Finland
Thorax CT examination
1.9
6.1
89
485
M04AA01
ATC
allopurinol; systemic
1.4
6.1
250
1785
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.0
6.1
32
107
C08CA07
ATC
nisoldipine; oral
3.0
6.1
32
107
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
6.1
183
1223
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.4
6.1
48
203
AA1
HP
Conventional CABG
2.7
6.1
38
142
ZY010
NOMESCO Finland
Hospital outpatient
1.8
6.1
100
567
C07AB12
ATC
nebivolol; oral
2.1
6.1
63
301
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
6.1
175
1159
L20.0
ICD-10 Finland
Besnier prurigo
1.6
6.1
136
847
4331X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]
12.5
6.1
10
8
I20.01
ICD-10 Finland
Unstable angina
2.2
6.1
58
269
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
6.1
72
366
N07BC02
ATC
methadone; systemic
8.6
6.0
12
14
R95
ICPC
Chron obstructive pulmonary disease
2.2
6.0
55
248
M54.8
ICD-10 Finland
Other dorsalgia
1.9
6.0
86
467
D07AC13
ATC
mometasone; topical
1.3
6.0
652
5415
J01FA06
ATC
roxithromycin; oral
1.2
6.0
936
8100
V03AE01
ATC
polystyrene sulfonate; oral
3.4
6.0
26
76
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
484
656
8.50
307.65
1.5
1.2
u/ml
3.8
2.9
0.29
74
67
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
593
680
10.45
307.65
1.9
1.7
g/l
0.2
0.2
9.48
577
638
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
455
524
9.94
307.65
1.5
1.2
u/ml
20.7
4.0
1.58
49
38
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
490
669
8.45
307.65
1.5
1.2
u/ml
15.5
7.0
1.08
103
120
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
580
768
8.98
307.65
2.1
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
656
958
8.34
307.65
1.4
1.2
u/ml
1.1
1.0
0.07
84
81
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
505
717
8.16
307.65
1.5
1.2
u/ml
23.0
46.9
0.79
29
46
(3037522) Nuclear Ab [Titer] in Serum
1304
3420
5.71
307.65
1.8
1.3
titre
1082.0
539.6
11.60
432
718
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
447
522
9.78
307.65
1.4
1.2
u/ml
15.2
7.0
—
14
8
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
600
708
10.18
307.65
1.8
1.7
g/l
1.0
1.2
19.69
583
666
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
355
536
7.32
227.86
1.4
1.2
u/ml
28.2
39.4
0.58
41
55
(3039162) Centromere protein B Ab [Units/volume] in Serum
277
311
9.65
227.65
1.4
1.2
u/ml
94.2
50.3
1.32
46
16
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
219
189
12.36
215.99
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
219
189
12.36
215.99
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
219
190
12.29
215.25
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
218
188
12.36
215.09
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
218
188
12.36
215.09
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
218
188
12.36
215.09
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
248
310
8.58
186.79
1.7
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1073
4498
3.07
180.73
1.4
1.3
iu/ml
35.8
33.4
0.16
331
1382
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1447
7492
2.69
159.26
2.4
2.1
u/l
136.9
199.2
3.73
1380
7023
(3001604) Monocytes [#/volume] in Blood
2067
12784
2.71
157.41
7.4
5.6
e9/l
0.5
0.6
13.65
1874
10993
(3006315) Basophils [#/volume] in Blood
2072
12840
2.71
156.99
7.4
5.6
e9/l
0.0
0.0
1.31
1880
11033
(3013115) Eosinophils [#/volume] in Blood
2106
13281
2.68
151.80
7.6
5.8
e9/l
0.2
0.2
1.13
1917
11611
(3019198) Lymphocytes [#/volume] in Blood
2076
13162
2.61
145.21
7.5
5.6
e9/l
1.8
1.9
7.07
1900
11557
(3038026) Centromere Ab [Units/volume] in Serum
178
203
9.22
143.78
1.5
1.1
u/ml
106.9
57.1
0.76
12
13
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
171
197
9.11
137.00
1.5
1.1
u/ml
64.7
50.8
—
7
8
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
171
198
9.06
136.45
1.5
1.1
u/ml
27.7
67.8
1.03
14
18
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
166
187
9.30
135.30
1.5
1.1
u/ml
20.6
3.6
0.91
13
13
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
944
4307
2.68
129.03
1.4
1.2
u/ml
6.2
11.9
2.54
371
1681
(42870588) Differential panel, method unspecified - Blood
1504
8618
2.39
124.93
7.2
5.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
124
106
12.12
122.49
1.1
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2183
14942
2.42
117.28
9.1
8.6
e9/l
3.8
4.1
7.66
1977
12984
(3022096) Basophils/100 leukocytes in Blood
1831
11654
2.32
116.16
7.8
5.8
%
0.8
0.7
8.29
1754
10832
(3006504) Eosinophils/100 leukocytes in Blood
1861
12018
2.29
112.75
7.8
5.7
%
2.9
2.8
1.58
1779
11163
(3019069) Monocytes/100 leukocytes in Blood
1865
12081
2.28
111.78
8.2
6.0
%
8.7
8.5
1.17
1790
11281
(3018010) Neutrophils/100 leukocytes in Blood
1865
12225
2.24
106.60
7.6
5.6
%
56.7
57.2
0.81
1785
11407
(3002030) Lymphocytes/100 leukocytes in Blood
1883
12412
2.24
105.87
7.9
5.8
%
28.6
28.1
1.14
1799
11532
(3023420) DNA double strand Ab [Units/volume] in Serum
162
259
6.53
97.33
1.7
1.6
iu/ml
28.4
20.4
—
8
14
(3013707) Erythrocyte sedimentation rate by Westergren method
2502
19239
2.33
87.08
6.3
4.0
mm/h
11.2
12.0
1.99
2404
17786
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
83
66
12.88
85.59
1.5
1.4
ug/l
7.8
9.2
1.89
83
66
(42529582) MDA5 Ab [Presence] in Serum by Line blot
74
57
13.26
77.74
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
74
57
13.26
77.74
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
74
57
13.26
77.74
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
74
57
13.26
77.74
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
251
751
3.54
69.91
1.6
1.6
titre
577.3
319.4
0.51
15
34
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
236
680
3.67
69.58
2.5
1.9
ug/l
336.7
749.9
0.69
216
631
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1128
6891
1.98
68.52
3.4
2.9
ng/l
1353.0
1264.1
0.30
986
5825
(3005719) IgG [Mass/volume] in Serum or Plasma
440
1858
2.58
66.33
2.6
2.7
g/l
10.5
10.6
0.25
407
1691
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2485
19861
2.08
66.24
8.9
7.2
u/l
73.7
77.4
3.87
2402
18650
(3037467) Urinalysis macro (dipstick) panel - Urine
2301
18001
1.96
63.70
5.6
4.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1749
12708
1.82
59.04
6.8
6.1
mmol/l
1.2
1.2
0.07
1473
10659
(3035350) Ketones [Presence] in Urine by Test strip
1737
12714
1.79
56.03
4.2
3.6
estimate
0.0
0.0
0.50
370
2407
(3009261) Glucose [Presence] in Urine by Test strip
1753
12907
1.78
55.02
4.3
3.6
estimate
0.0
0.0
1.32
375
2397
(40760892) CBC W Ordered Manual Differential panel - Blood
941
5752
1.90
54.61
5.3
4.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
1148
7488
1.83
54.06
4.1
3.7
ph
7.4
7.4
1.76
203
1424
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1593
11453
1.77
53.84
5.9
5.4
mmol/l
1.2
1.2
0.98
1477
10321
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
428
1983
2.34
52.02
3.3
2.9
ng/l
188.0
178.3
0.19
391
1778
(3015736) pH of Urine
1408
9838
1.76
51.96
3.8
3.3
—
5.8
—
0
9
(3021601) Nitrite [Presence] in Urine by Test strip
1723
12756
1.75
51.78
5.6
4.9
estimate
0.0
0.0
0.50
374
2445
(3028026) IgM [Mass/volume] in Serum or Plasma
335
1462
2.44
46.36
1.8
1.8
g/l
1.3
1.4
0.62
306
1329
(3004588) Protein electrophoresis panel - Serum or Plasma
364
1674
2.32
44.69
1.7
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
932
5995
1.78
44.14
4.0
3.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
406
1990
2.19
42.66
1.8
2.7
g/l
67.0
66.7
0.48
375
1823
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
130
350
3.83
42.15
1.3
1.2
u/ml
3.3
3.6
0.18
55
152
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1476
10864
1.66
42.02
2.6
2.2
nmol/l
78.8
78.0
0.56
1362
9712
(3013293) Extractable nuclear Ab [Presence] in Serum
45
43
10.60
41.11
1.6
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
130
360
3.72
40.47
1.3
1.2
u/ml
3.1
3.4
0.08
42
117
(3018095) Leukocytes [#/volume] in Urine
1263
9036
1.65
39.44
4.1
3.5
e6/l
87.8
109.6
0.23
892
6323
(3024561) Albumin [Mass/volume] in Serum or Plasma
1468
10964
1.62
38.18
5.0
4.4
g/l
35.7
35.7
0.11
1383
10159
(3007164) IgA [Mass/volume] in Serum or Plasma
795
5088
1.75
37.30
1.5
1.4
g/l
2.3
2.4
0.22
511
3082
(3029937) Albumin [Presence] in Urine by Test strip
993
6888
1.64
33.82
4.8
4.0
estimate
0.0
0.0
1.49
368
2372
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
71
144
5.02
33.11
1.4
1.5
u/l
5.8
6.0
0.10
63
125
(3021589) Normoblasts [#/volume] in Blood
1493
11469
1.56
32.65
11.4
8.9
e9/l
0.0
0.0
1.81
1241
9312
(3026493) Urate [Moles/volume] in Serum or Plasma
935
6448
1.63
32.32
3.1
2.5
umol/l
3406.9
5321.5
0.75
843
5574
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
120
377
3.27
30.78
1.4
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
570
3514
1.76
29.72
3.0
2.2
g/l
2.4
2.3
0.51
528
3238
(4268621)
92
249
3.77
29.64
2.3
2.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
610
3859
1.72
28.93
3.0
2.2
umol/l
12.3
13.5
3.37
567
3562
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1299
9864
1.53
28.76
4.5
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
980
7025
1.57
28.00
3.4
3.0
e6/l
0.3
0.5
2.52
769
5286
(36304419) Bacteria [Presence] in Urine
959
6853
1.57
27.72
3.3
3.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1293
9865
1.52
27.69
9.3
8.4
inr
1.2
1.2
1.19
370
2906
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
527
3244
1.75
27.44
3.1
2.3
%
21.3
23.4
2.53
447
2783
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
59
121
4.95
27.19
1.2
1.2
u/ml
6.5
2.6
—
6
13
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
925
6584
1.57
27.09
2.8
2.1
mg/l
2.9
2.9
0.13
813
5583
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
227
1063
2.22
26.35
1.6
1.8
u/l
38.8
39.3
0.15
198
947
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
200
896
2.31
25.80
1.7
2.4
g/l
9.8
10.3
0.94
167
769
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
200
899
2.31
25.60
1.7
2.4
g/l
3.0
3.1
0.60
160
716
(3036481) Cortisol [Moles/volume] in Serum or Plasma
413
2417
1.81
25.43
2.3
2.1
nmol/l
393.7
370.4
1.19
391
2205
(3019150) Specific gravity of Urine by Refractometry
800
5575
1.58
25.42
4.6
4.0
kg/l
1.0
1.0
1.73
123
822
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
208
959
2.25
25.06
1.7
2.4
g/l
7.2
7.4
0.80
160
730
(3007853) Bacteria identified in Skin by Aerobe culture
460
2791
1.76
25.03
2.2
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
207
958
2.24
24.71
1.7
2.3
g/l
3.5
3.8
3.85
156
695
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
207
959
2.24
24.65
1.7
2.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
773
5378
1.57
24.62
2.9
2.5
e6/l
4.6
6.2
3.02
695
4706
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1457
11584
1.47
24.47
3.6
2.7
ug/l
102.9
114.8
0.76
1364
10711
(3002582) Erythrocytes [#/volume] in Urine
1030
7648
1.51
24.30
3.6
3.1
e6/l
59.8
89.4
0.54
819
5842
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
444
2692
1.75
24.17
3.9
4.1
u/l
247.2
244.7
0.12
417
2538
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
791
5563
1.56
23.92
1.9
1.7
mg/l
1.2
1.1
0.14
591
4204
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1626
13266
1.45
23.51
6.1
6.0
umol/l
10.4
11.3
3.39
1542
12548
(3027945) Reticulocytes/100 erythrocytes in Blood
436
2661
1.74
23.13
2.7
2.4
%
1.8
1.8
0.17
383
2349
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
822
5870
1.54
23.07
1.4
1.3
u/ml
2.1
1.5
0.42
195
1561
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1054
7933
1.49
22.98
2.6
2.5
u/l
60.2
57.8
0.90
970
7295
(3042936) Bacteria identified in Isolate by Culture
520
3347
1.66
22.60
2.3
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
628
4244
1.60
22.39
2.8
2.6
e6/l
0.9
1.2
1.95
392
2369
(40758558) Short blood count panel - Blood
892
6519
1.51
22.34
7.1
6.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
340
1969
1.81
21.53
2.9
2.5
e9/l
70.3
69.7
0.09
267
1483
(3002179) Metamyelocytes/100 leukocytes in Blood
339
1967
1.81
21.32
4.5
3.8
%
0.6
0.6
0.10
61
438
(40761535) Cells panel - Urine sediment
358
2112
1.78
21.29
4.0
3.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
364
2158
1.77
21.29
4.8
4.0
%
0.7
0.8
0.53
83
600
(3021960) Folate [Moles/volume] in Serum or Plasma
818
5921
1.51
21.27
1.6
1.5
nmol/l
20.1
20.8
0.64
718
5034
(3018677) aPTT in Platelet poor plasma by Coagulation assay
544
3597
1.62
21.12
2.3
2.0
s
30.2
29.6
1.43
530
3476
(3003458) Phosphate [Moles/volume] in Serum or Plasma
479
3070
1.66
21.06
5.9
5.1
mmol/l
1.1
1.0
2.33
448
2843
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
175
809
2.23
20.95
1.8
2.5
g/l
0.6
1.0
1.19
156
711
(3021440) Promyelocytes/100 leukocytes in Blood
349
2056
1.78
20.84
4.8
4.1
%
0.1
0.1
1.20
77
558
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
165
750
2.26
20.57
1.6
2.3
g/l
38.2
37.9
0.21
147
649
(3031040) Bacteria [#/volume] in Urine by Automated count
2025
17440
1.43
20.45
5.3
4.4
e6/l
6229.0
1648.3
0.38
18
228
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
308
1761
1.83
20.30
2.5
2.4
au/ml
32.3
23.3
—
8
99
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
287
1611
1.86
20.06
1.3
1.3
au/ml
77.0
47.1
—
7
70
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1207
9507
1.43
20.04
4.1
3.4
ng/l
34.7
106.5
0.80
793
6297
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
158
713
2.28
20.04
1.7
2.4
g/l
0.0
0.0
0.49
146
665
(3025159) Blasts/100 leukocytes in Blood
328
1938
1.77
19.35
4.8
4.1
%
0.0
0.5
0.96
63
476
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
52
128
4.11
19.18
1.1
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
147
656
2.30
19.15
1.7
2.4
g/l
0.0
0.0
0.00
136
618
(3029075) Extractable nuclear Ab panel - Serum
39
76
5.18
19.09
1.2
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
98
362
2.76
19.00
1.4
1.5
g/l
0.5
0.8
1.59
78
278
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
148
665
2.28
18.97
1.7
2.4
g/l
0.0
0.0
0.00
136
619
(3011436) Histone Ab [Units/volume] in Serum
32
52
6.21
18.92
1.1
1.1
u/ml
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
56
148
3.83
18.75
1.3
1.1
ratio
1.0
1.0
0.33
20
58
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1302
10492
1.40
18.58
2.1
2.0
pmol/l
97.3
95.5
0.67
694
5393
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
157
744
2.17
17.69
1.5
1.6
iu/ml
15.4
9.5
0.13
28
145
(3012095) Magnesium [Moles/volume] in Serum or Plasma
568
3950
1.53
17.42
3.5
3.2
mmol/l
0.8
0.8
0.33
523
3686
(3008898) HLA-B27 [Presence]
180
908
2.04
17.22
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
38
80
4.79
17.05
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2282
20385
1.41
16.62
4.6
4.1
pmol/l
14.7
14.7
0.04
2129
18568
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
658
4786
1.47
16.09
4.8
3.5
ng/l
214.3
416.6
2.41
519
3598
(3034770) Mitochondria Ab [Titer] in Serum
141
668
2.16
15.92
1.3
1.2
titre
1053.7
1158.4
0.08
16
25
(3023368) Bacteria identified in Blood by Culture
859
6577
1.42
15.90
4.7
4.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
463
3141
1.55
15.78
2.3
2.2
ug/g
122.4
124.6
0.05
367
2450
(3027801) Oxygen [Partial pressure] in Arterial blood
407
2683
1.59
15.71
5.9
6.9
kpa
12.3
12.4
0.12
384
2548
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
407
2684
1.59
15.68
5.9
6.9
kpa
5.1
5.1
0.41
383
2548
(3019309) Folate [Moles/volume] in Red Blood Cells
642
4685
1.46
15.35
1.8
1.8
nmol/l
1151.9
1159.9
0.08
506
3539
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
152
754
2.07
15.24
3.0
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2790
26006
1.53
15.13
20.0
13.2
mg/l
20.9
23.1
2.96
2281
20496
(3000494) Fungus identified in Specimen by Culture
434
2942
1.55
14.79
1.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
189
1024
1.90
14.73
2.0
1.8
g/l
1.4
1.5
0.35
161
882
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
134
642
2.13
14.72
1.6
2.0
mg/l
10.5
11.0
0.37
127
591
(3017143) Hepatitis C virus Ab [Presence] in Serum
418
2815
1.56
14.66
1.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
400
2671
1.57
14.56
5.9
6.9
mmol/l
1.2
1.1
0.09
312
2073
(3016502) Oxygen saturation in Arterial blood
362
2362
1.60
14.54
6.2
7.3
%
95.3
95.7
0.58
344
2275
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
355
2312
1.60
14.37
2.3
2.2
g/l
0.2
0.2
0.08
332
2171
(40768443) Skin Pathology biopsy report
195
1077
1.86
14.32
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
337
2177
1.61
14.10
6.2
7.6
g/l
119.8
122.0
1.13
320
2096
(40768797) Stomach Pathology biopsy report
503
3557
1.49
14.00
1.3
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
135
664
2.08
13.87
1.3
1.2
titre
87.8
104.4
—
9
50
(3036489) Thrombin time
165
880
1.92
13.50
2.0
2.0
s
21.0
21.3
0.33
145
764
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
133
658
2.07
13.46
2.3
2.4
%
176.6
181.7
0.26
127
628
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
140
706
2.03
13.45
2.1
2.2
%
95.7
92.4
0.88
133
654
(3044927) Protein electrophoresis panel - Urine
68
253
2.72
13.11
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
266
1651
1.67
13.03
1.2
1.3
u/ml
183.0
203.7
0.21
247
1523
(3014576) Chloride [Moles/volume] in Serum or Plasma
420
2904
1.51
12.98
6.6
5.9
mmol/l
104.5
104.4
0.17
411
2843
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
402
2756
1.52
12.93
1.9
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
307
1981
1.61
12.88
8.7
6.4
mmol/l
10.0
9.3
0.95
292
1888
(3013826) Glucose [Moles/volume] in Serum or Plasma
1714
14936
1.31
12.82
5.2
4.3
mmol/l
6.4
6.7
4.63
1641
13890
(3019060) Gas panel - Arterial blood
252
1554
1.67
12.66
4.1
4.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1083
8861
1.33
12.66
2.9
3.3
mmol/l
2.3
2.4
1.82
959
7726
(3015183) Erythrocyte sedimentation rate
44
131
3.39
12.45
1.3
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
810
6361
1.36
12.36
4.9
3.6
%
91.4
90.7
0.33
788
6183
(3026782) Osmolality of Urine
658
4995
1.40
12.36
3.0
2.7
mosm/kgh2o
521.8
546.7
2.28
567
4253
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
398
2748
1.51
12.36
1.9
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
875
6961
1.35
12.27
3.8
3.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
316
2080
1.58
12.18
1.3
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
53
180
2.98
12.09
1.3
1.2
titre
182.5
129.1
0.20
12
33
(3028192) IgG subclass 2 [Mass/volume] in Serum
62
231
2.72
11.95
1.3
1.4
g/l
2.8
2.9
0.21
46
161
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
115
564
2.08
11.94
1.5
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
60
220
2.76
11.92
1.8
2.4
e9/l
0.9
1.2
2.57
39
145
(3008152) Bicarbonate [Moles/volume] in Arterial blood
234
1453
1.66
11.45
5.8
6.7
mmol/l
24.9
24.6
0.74
216
1350
(3024139) IgG subclass 3 [Mass/volume] in Serum
61
231
2.67
11.41
1.3
1.4
g/l
0.5
0.4
0.75
45
161
(3027135) IgG subclass 1 [Mass/volume] in Serum
61
231
2.67
11.41
1.3
1.4
g/l
5.9
6.6
1.14
44
161
(3002385) Erythrocyte distribution width [Ratio]
2347
21567
1.32
10.91
22.8
16.0
%
13.8
13.7
4.48
2305
21059
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
32
85
3.79
10.74
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2580
24086
1.35
10.42
5.6
4.9
mu/l
1.9
2.1
1.32
2443
22085
(44806071)
17
27
6.32
10.27
1.1
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
534
4033
1.39
10.16
2.1
1.8
—
—
—
0
0
(4062490)
59
234
2.55
10.10
1.3
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
49
177
2.80
10.06
1.8
2.2
%
16.2
14.0
0.40
21
75
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
277
1873
1.52
9.45
4.0
3.4
ng/l
91.1
83.4
0.65
242
1599
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
981
8175
1.29
9.38
3.6
3.1
u/l
47.9
32.6
0.42
929
7770
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
391
2838
1.43
9.32
2.5
2.7
umol/l
5.8
8.1
3.88
340
2455
(4306422)
76
353
2.18
9.16
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
517
3965
1.36
8.87
3.2
2.8
e6/l
2.6
2.8
0.28
280
2105
(3000492) Spirometry study
332
2359
1.45
8.86
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
264
1792
1.52
8.85
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
86
425
2.05
8.84
1.2
1.4
u/ml
95.8
118.2
0.85
15
86
(3026008) Bacteria identified in Urine by Culture
963
8057
1.28
8.81
3.4
3.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
425
3167
1.39
8.69
29.5
23.4
inr
1.4
1.3
0.58
58
483
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
93
476
1.98
8.69
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
279
1925
1.49
8.65
9.0
7.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
175
2.65
8.61
1.8
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
125
707
1.80
8.61
3.2
3.2
u/ml
0.4
0.4
0.08
68
383
(3037756) Immunofixation for Serum or Plasma
96
499
1.95
8.59
1.3
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
1963
17873
1.25
8.47
4.4
3.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
118
660
1.82
8.43
1.5
1.3
u/l
9.5
11.2
0.66
97
539
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
689
5548
1.31
8.42
1.6
1.7
pmol/l
445.9
26989007.1
4.19
581
4639
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
23
58
3.99
8.33
1.3
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
130
753
1.76
8.27
2.0
3.5
mg/l
36.5
59.5
1.50
105
620
(3000570) Elastase.pancreatic [Mass/mass] in Stool
129
746
1.76
8.25
1.5
1.4
ug/g
290.1
288.0
0.04
82
413
(46235355) HIV 1 and 2 tests - Meaningful Use set
585
4623
1.32
8.16
1.8
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
291
2050
1.46
8.12
6.2
6.2
mmol/l
1.4
1.3
0.13
276
1976
(4010399)
255
1760
1.49
7.90
1.5
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
125
727
1.75
7.86
2.0
3.5
ratio
1.1
1.6
1.21
12
59
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
128
750
1.74
7.84
2.0
3.5
mg/l
28.9
71.9
1.55
103
618
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
73
357
2.07
7.77
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
215
1437
1.53
7.76
1.6
1.5
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
25
71
3.54
7.69
1.0
1.4
nmol/l
151.5
122.9
0.25
16
55
(3017732) Neutrophils [#/volume] in Blood
259
1806
1.47
7.62
3.3
3.0
e9/l
4.0
4.0
0.07
196
1421
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
21
53
3.98
7.61
1.1
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
39
146
2.69
7.57
1.6
2.6
e6/l
357.0
541.6
1.41
32
128
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
119
694
1.74
7.43
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
277
1967
1.45
7.42
3.2
2.6
ml/min/173m2
63.2
67.5
1.19
111
785
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
495
3883
1.32
7.22
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
100
560
1.81
7.17
1.8
3.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
86
460
1.89
7.13
8.6
5.2
iu/ml
2775.9
654.4
0.59
15
63
(3003327) Ova and parasites identified in Stool by Light microscopy
134
818
1.67
7.09
2.0
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1369
12165
1.22
6.81
4.8
3.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
84
454
1.87
6.76
1.1
1.2
u/ml
282.5
261.2
0.28
56
274
(3002032) Base excess in Venous blood by calculation
293
2142
1.40
6.69
5.9
3.3
mmol/l
1.7
2.0
0.95
252
1720
(3021447) Carbon dioxide [Partial pressure] in Venous blood
293
2146
1.40
6.62
5.9
3.3
kpa
5.9
5.8
0.74
284
2078
(4027681)
38
151
2.53
6.60
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
184
1234
1.52
6.58
7.9
9.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
43
182
2.38
6.53
1.1
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
36
140
2.59
6.53
1.6
2.7
e9/l
0.2
0.2
1.09
31
127
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
99
571
1.76
6.47
1.2
1.5
e6/l
1257.5
1363.7
0.03
78
462
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
209
1451
1.47
6.32
7.2
8.2
%
0.7
0.7
0.27
209
1443
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
108
645
1.70
6.25
1.3
1.3
mg/l
432.3
534.6
1.80
103
608
(21494814) CD8 cells/100 lymphocytes in Specimen
28
98
2.87
6.20
2.0
2.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
98
571
1.74
6.20
1.2
1.4
e6/l
9.1
28.2
0.86
75
437
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
209
1457
1.46
6.20
7.1
8.1
%
1.4
1.3
1.26
209
1450
(1761868) Lipid panel - Serum or Plasma
762
8930
0.81
6.05
2.6
2.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
24
78
3.09
6.03
1.2
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
259
1890
1.40
5.99
1.2
1.2
iu/ml
130.6
147.3
0.28
95
703
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
50
235
2.15
5.98
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
302
2262
1.37
5.97
4.6
3.9
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
13
27
4.83
5.97
1.9
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
162
1082
1.52
5.93
6.5
3.7
mmol/l
23.9
24.2
0.74
139
978
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
86
489
1.78
5.93
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
731
6166
1.24
5.86
2.9
2.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
36
148
2.45
5.86
1.1
1.1
u/l
1.0
1.1
0.73
17
79
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
274
2028
1.38
5.83
2.4
2.3
ug/l
6.0
6.3
0.16
231
1769
(3051611) Lipemic interference index of Serum or Plasma
50
238
2.12
5.80
3.5
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
85
486
1.77
5.76
1.7
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
29
108
2.70
5.75
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
584
4816
1.26
5.71
2.7
2.9
mmol/l
2.4
2.4
1.42
515
4222
(3044290) Cell count panel - Cerebral spinal fluid
90
525
1.73
5.70
1.2
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
53
261
2.05
5.63
1.6
1.5
mosm/kgh2o
276.8
278.3
0.23
43
196
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1814
16740
1.19
5.54
3.3
3.0
u/l
45.7
45.5
0.03
1702
15599
(3022145) Colonoscopy Study observation
364
2836
1.32
5.54
1.4
1.3
—
—
—
0
0
(4034850)
132
860
1.56
5.43
15.0
8.9
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
349
1.88
5.42
3.8
2.9
u/ml
8445.8
1668.4
—
5
31
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
108
676
1.62
5.27
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
338
2631
1.32
5.18
4.0
4.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
238
1758
1.38
5.15
4.3
2.7
kpa
4.4
4.6
0.64
228
1697
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
140
937
1.52
5.12
2.0
1.9
ug/l
1.9
2.2
0.15
128
818
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
69
385
1.81
5.11
1.2
1.2
u/l
26.2
34.5
0.50
64
332
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
94
573
1.66
5.10
1.2
1.3
mmol/l
3.7
3.7
0.11
85
533
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
244
2.02
5.09
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
239
1773
1.38
5.04
1.7
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2841
27465
1.28
5.04
21.8
15.3
umol/l
77.9
75.1
3.17
2841
27455
(40768804) Tissue Pathology biopsy report
1209
10837
1.18
5.01
2.2
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
23
82
2.82
4.97
2.2
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
85
509
1.69
4.95
2.0
2.1
g/l
123.5
129.4
0.96
50
368
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
174
1226
1.44
4.94
7.6
8.6
mmol/l
23.9
24.3
0.89
154
1144
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
228
1690
1.38
4.84
2.6
3.3
pmol/l
4.3
4.5
1.17
199
1494
(3023419) Bacteria identified in Sputum by Culture
58
312
1.87
4.84
3.1
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
117
767
1.55
4.73
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
34
151
2.26
4.72
1.7
2.6
e6/l
679.9
721.7
0.13
15
61
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
59
322
1.85
4.72
1.1
1.1
g/l
1.5
1.5
0.19
54
292
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
13
33
3.95
4.71
1.3
1.6
ng/l
171.4
119.8
0.26
13
33
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
112
728
1.56
4.70
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
56
303
1.86
4.61
1.6
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
922
8120
1.19
4.60
2.8
2.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
94
593
1.60
4.50
1.6
1.7
e6/l
13298.1
13149.7
0.01
64
432
(3019550) Sodium [Moles/volume] in Serum or Plasma
2757
26627
1.24
4.47
20.7
15.0
mmol/l
139.4
139.7
6.87
2703
25927
(3023103) Potassium [Moles/volume] in Serum or Plasma
2764
26704
1.24
4.45
20.9
15.1
mmol/l
4.0
4.0
2.90
2710
25953
(3052851) Hemolysis interference index of Serum or Plasma
111
730
1.54
4.45
4.2
3.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
184
1340
1.40
4.37
2.5
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
61
346
1.78
4.34
1.4
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
45
3.34
4.32
1.1
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
192
1415
1.38
4.26
3.8
2.8
g/l
124.6
129.2
2.20
184
1382
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
22
84
2.63
4.22
1.5
2.4
%
27.0
27.8
0.09
22
78
(40768441) Liver Pathology biopsy report
37
179
2.08
4.20
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
410
1.70
4.19
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
90
574
1.58
4.14
1.3
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
192
1425
1.37
4.09
6.1
6.8
mmol/l
24.4
24.9
1.16
192
1416
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
148
1052
1.43
4.06
3.0
2.3
%
0.7
0.7
1.30
143
1015
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
47
3.20
4.05
1.1
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
271
2122
1.30
4.01
4.0
3.4
mmol/l
1.2
1.2
0.14
249
1836
(3023410) Appearance of Cerebral spinal fluid
48
260
1.86
3.98
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
388
3181
1.25
3.96
7.9
6.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
41
211
1.96
3.96
1.1
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
136
957
1.44
3.95
5.1
5.6
%
1.7
1.6
0.60
127
894
(3045414) Leukocytes [Presence] in Urine
164
1194
1.39
3.94
1.8
1.9
—
—
—
0
0
(3020891) Body temperature
136
958
1.44
3.93
4.3
4.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
34
164
2.08
3.91
2.0
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
42
219
1.93
3.91
1.4
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
82
520
1.59
3.89
5.9
8.1
mmol/l
11.0
11.2
0.20
74
464
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
36
178
2.03
3.89
1.7
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
82
521
1.59
3.86
5.9
8.1
mmol/l
104.0
105.3
1.22
74
465
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
93
609
1.54
3.85
2.9
3.2
mg/l
1.5
1.5
0.21
88
552
(3017446) Testosterone [Moles/volume] in Serum or Plasma
194
1458
1.35
3.83
2.4
2.1
nmol/l
12.2
12.0
0.12
164
1278
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
151
1090
1.40
3.82
2.0
2.1
u/l
4196.2
5554.7
0.20
42
426
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
104
700
1.50
3.79
1.3
1.3
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
21
83
2.54
3.79
1.5
2.4
%
8.7
9.9
0.27
21
75
(3047181) Lactate [Moles/volume] in Blood
112
766
1.48
3.78
5.4
6.6
mmol/l
1.2
1.3
0.57
99
667
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
14
44
3.19
3.77
2.2
3.9
ng/l
91.4
183.5
—
9
21
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
292
2331
1.28
3.74
2.4
2.3
u/l
69.9
37.8
0.72
254
1981
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2836
27568
1.23
3.74
13.6
10.0
u/l
23.3
25.2
11.51
2778
26538
(3024928) Oxygen saturation in Venous blood
76
479
1.60
3.71
3.7
2.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
10
25
4.01
3.70
1.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
70
433
1.63
3.69
1.5
1.3
mmol/l
59.9
62.3
0.17
52
355
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
38
196
1.95
3.67
1.4
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
23
501
0.46
3.66
2.4
3.9
u/ml
22.8
33.3
0.72
23
487
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
52
298
1.76
3.63
1.4
1.3
nmol/l
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
133
948
1.42
3.63
5.3
5.7
%
0.9
0.9
0.01
125
886
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
31
149
2.09
3.62
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
318
2577
1.26
3.60
3.7
3.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
47
262
1.81
3.60
1.2
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
110
761
1.46
3.53
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
109
753
1.46
3.52
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
28
131
2.15
3.51
4.0
3.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
133
955
1.41
3.49
1.6
1.6
mu/l
258.3
296.1
0.91
123
861
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
17
63
2.71
3.48
1.6
2.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
103
708
1.47
3.42
3.6
3.5
mmol/l
3.9
3.9
1.03
103
664
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
25
113
2.22
3.41
1.9
2.8
u/ml
1039.6
982.2
0.06
25
113
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
44
245
1.81
3.40
1.1
1.2
u/l
55.8
54.9
0.08
37
173
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
133
2.11
3.39
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
110
768
1.45
3.38
1.2
1.2
—
—
—
0
0
(44790048)
47
268
1.76
3.36
2.0
1.4
—
—
—
0
0
(44806118)
47
268
1.76
3.36
2.0
1.4
—
—
—
0
0
(44790047)
47
268
1.76
3.36
2.0
1.4
—
—
—
0
0
(44790049)
47
268
1.76
3.36
2.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
163
2151
0.74
3.34
1.7
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
39
211
1.86
3.30
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
43
243
1.78
3.18
3.4
3.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
344
2854
1.23
3.18
1.6
1.7
%
1.6
1.5
3.29
302
2508
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
551
4782
1.18
3.16
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
144
2.02
3.15
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
15
55
2.74
3.15
4.4
3.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
329
3949
0.81
3.12
2.8
3.1
ug/l
0.7
0.8
2.45
233
2667
(3006653) Thiamine [Moles/volume] in Blood
28
138
2.04
3.11
1.2
1.4
nmol/l
120.0
137.2
1.65
28
138
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
103
723
1.44
3.10
1.1
1.1
u/ml
8.8
4.6
—
7
90
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
56
344
1.64
3.09
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
321
1.66
3.09
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
179
2301
0.76
3.06
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
86
587
1.48
3.00
1.9
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
151
1138
1.34
3.00
4.4
2.8
mmol/l
25.1
25.4
0.25
146
1103
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
62
394
1.58
2.99
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
94
656
1.45
2.94
1.5
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
63
404
1.57
2.93
1.3
1.4
u/l
17.9
25.3
1.20
55
336
(3023323) Follitropin [Units/volume] in Serum or Plasma
174
1344
1.31
2.92
1.4
1.4
iu/l
25.4
28.2
0.53
149
1162
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
25
121
2.07
2.92
1.6
1.7
nmol/l
4.9
4.6
0.03
17
98
(3043238) Trisomy 21 risk [Likelihood] in Fetus
33
583
0.56
2.83
1.5
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
118
865
1.38
2.81
2.4
3.1
g/l
0.2
0.3
0.84
39
343
(3047007) Chlamydophila sp Ab [Presence] in Serum
59
377
1.58
2.80
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
59
377
1.58
2.80
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
32
568
0.56
2.80
1.4
1.4
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
16
65
2.47
2.78
1.3
1.3
%
21.5
26.5
0.30
11
43
(3000060) B lymphocytes [#/volume] in Blood
15
59
2.55
2.78
1.5
2.4
e6/l
121.1
222.6
—
9
31
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
37
209
1.78
2.78
1.4
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
32
565
0.56
2.75
1.4
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
12
42
2.86
2.75
2.8
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
83
574
1.46
2.74
1.9
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
50
309
1.63
2.73
2.1
1.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
20
91
2.21
2.73
1.1
1.1
%
96.1
89.5
0.33
13
54
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546
4802
1.16
2.66
1.7
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
48
296
1.63
2.65
1.5
1.6
%
64.5
59.8
0.34
31
184
(3010144) Erythrocytes [#/volume] in Synovial fluid
39
228
1.72
2.63
1.3
1.3
e6/l
14297.4
96859.6
1.15
26
158
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
113
2.04
2.61
1.2
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
113
2.04
2.61
1.2
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
50
313
1.61
2.61
1.2
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
7
7.15
2.55
1.2
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
33
3.04
2.52
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
477
1.48
2.52
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
62
412
1.51
2.51
1.4
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
22
108
2.04
2.51
3.4
3.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
54
349
1.56
2.48
2.1
2.2
umol/l
7.1
7.3
0.02
40
250
(3003338) MCHC [Mass/volume]
2280
21979
1.13
2.48
25.4
17.1
g/l
331.1
332.1
6.08
2267
21800
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
47
294
1.61
2.48
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
749
6775
1.14
2.45
1.7
1.6
mmol/l
1.2
1.3
3.80
637
5712
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
30
166
1.81
2.44
1.7
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
13
51
2.56
2.44
1.1
1.3
umol/l
16.5
17.1
—
8
45
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
49
311
1.58
2.44
2.7
2.1
mg/l
21.3
24.5
0.23
15
77
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
20
96
2.09
2.42
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
184
1473
1.26
2.40
1.9
1.6
—
—
—
0
0
(4015189)
15
64
2.35
2.38
2.2
2.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
39
235
1.67
2.38
1.7
2.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
90
2.12
2.38
1.1
1.3
%
94.1
89.6
0.17
13
54
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
70
483
1.46
2.38
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
70
483
1.46
2.38
1.4
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
52
2.51
2.35
5.3
8.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
65
444
1.47
2.33
1.5
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
30
169
1.78
2.32
1.7
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
71
1003
0.70
2.31
1.5
1.7
mg/l
4.5
3.8
0.24
36
695
(3003434) Protein [Mass/volume] in Pleural fluid
46
292
1.58
2.30
1.3
1.4
g/l
33.4
33.1
0.04
36
264
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
13
4.62
2.27
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
8
23
3.48
2.27
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
49
737
0.66
2.23
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
183
1478
1.25
2.23
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
33
195
1.70
2.19
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
38
234
1.63
2.16
1.1
1.0
—
—
—
0
0
(3013512) EKG study
805
7368
1.12
2.15
4.5
3.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
145
1.80
2.10
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
54
364
1.49
2.10
1.3
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
25
3.21
2.09
15.3
6.0
mmol/l
7.5
6.1
—
8
25
(40768800) Prostate Pathology biopsy report
26
446
0.58
2.09
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
66
464
1.43
2.08
3.5
2.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
108
825
1.32
2.05
1.4
1.3
miu/ml
181.6
214.0
0.51
46
404
(3023199) Leukocytes [#/volume] in Pleural fluid
42
270
1.56
2.03
1.4
1.4
e6/l
2845.0
1820.6
0.68
25
193
(37021550) Renin [Units/volume] in Plasma --upright
12
50
2.41
2.02
2.0
1.4
mu/l
65.5
37.6
0.60
12
37
(40768806) Pleura Pathology biopsy report
37
231
1.61
2.02
1.3
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
38
2.64
2.01
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
167
1355
1.25
1.99
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
369
1.47
1.98
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
47
312
1.51
1.98
1.8
1.5
mu/l
59.1
40.7
0.47
41
283
(3000012) Reticulocyte production index
22
119
1.85
1.97
1.6
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
61
428
1.43
1.96
2.0
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
48
321
1.50
1.96
3.1
2.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
20
105
1.91
1.95
2.2
1.9
mmol/l
8.5
9.5
0.57
11
87
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
51
2.36
1.95
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
121
947
1.29
1.94
1.5
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
64
2.19
1.94
1.2
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
31
187
1.66
1.94
2.0
2.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
68
488
1.40
1.93
2.7
2.9
umol/l
39.7
34.0
0.52
57
411
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
183
1505
1.23
1.93
5.0
3.6
kpa
5.2
5.2
0.02
173
1388
(3024869) Neuronal Ab [Presence] in Serum
10
39
2.57
1.92
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
91
686
1.34
1.91
1.2
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
141
0.35
1.87
15.8
12.0
mmol/l
0.6
0.6
—
5
129
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
20
107
1.87
1.86
1.5
2.0
ug/l
23.2
94.2
0.46
20
93
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
73
2.06
1.80
1.7
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
61
436
1.41
1.79
1.5
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
47
678
0.69
1.79
1.3
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
37
239
1.55
1.78
1.2
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
174
1438
1.22
1.77
4.8
3.5
mmol/l
1.4
1.8
1.08
135
1060
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
116
1458
0.79
1.77
1.5
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
179
1486
1.22
1.75
4.9
3.6
ph
7.4
7.4
0.86
17
169
(3021788) Differential panel - Synovial fluid
62
447
1.39
1.74
1.5
1.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
88
1.94
1.74
1.8
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
27
162
1.67
1.74
1.6
1.5
u/l
12.0
6.7
0.73
18
79
(3015235) Bicarbonate [Moles/volume] in Capillary blood
78
584
1.34
1.74
3.9
2.9
mmol/l
24.6
25.1
0.47
72
501
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
81
1.98
1.74
1.8
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1728
16571
1.09
1.74
3.2
3.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
24
2.92
1.72
1.1
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
37
242
1.54
1.70
1.5
1.4
e6/l
29458.1
59248.0
0.42
18
144
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
43
291
1.48
1.69
2.5
3.1
nmol/l
10.6
22.6
0.27
43
284
(3017569) Oxygen content in Arterial blood
20
111
1.81
1.68
1.8
2.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
48
680
0.70
1.67
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
55
392
1.41
1.66
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
48
679
0.70
1.66
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
46
318
1.45
1.64
1.3
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
48
677
0.70
1.64
1.3
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
237
0.50
1.60
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
206
1751
1.19
1.59
3.0
3.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
53
380
1.40
1.57
1.7
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
40
272
1.48
1.56
3.2
3.9
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
26
160
1.63
1.55
1.0
1.4
—
526.0
—
0
15
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
105
1310
0.79
1.54
1.5
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
133
1089
1.23
1.52
5.0
3.8
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
23
138
1.67
1.51
1.4
1.6
u/field
1.1
2.1
1.10
18
98
(3049717) Cytology report of Urine Cyto stain
112
901
1.25
1.50
2.3
2.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
40
276
1.45
1.47
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
45
2.23
1.46
3.6
2.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
38
2.37
1.45
1.0
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
7
28
2.50
1.45
1.7
1.9
mg/l
1.1
1.3
—
7
20
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
45
319
1.42
1.44
1.2
1.4
—
—
—
0
0
(4035726)
260
2274
1.16
1.44
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
58
430
1.36
1.43
1.1
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
39
2.31
1.43
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
154
0.45
1.42
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2489
24352
1.10
1.42
16.9
12.3
ml/min/173m2
81.3
81.5
0.18
2142
19973
(3028433) Virus identified in Specimen by Culture
15
81
1.86
1.40
1.3
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2752
27064
1.11
1.39
17.5
12.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
31
206
1.51
1.37
1.2
1.2
nmol/l
289.1
370.0
1.67
23
189
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
30
198
1.52
1.37
1.1
1.0
mg/l
311.6
293.9
0.53
25
180
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
38
264
1.44
1.36
1.2
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
41
290
1.42
1.34
1.5
1.7
—
1190.0
—
0
8
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
107
870
1.24
1.34
1.5
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
47
2.13
1.33
3.5
8.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
47
2.13
1.33
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
42
2.15
1.33
3.2
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
11
54
2.04
1.32
1.1
1.1
%
70.2
68.5
—
5
18
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
11
54
2.04
1.32
1.1
1.1
%
81.0
77.2
—
5
19
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
113
1.69
1.31
1.2
1.1
miu/ml
1969.4
1543.9
0.66
19
113
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
152
1.58
1.31
1.3
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
283
0.60
1.31
1.2
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
15
83
1.81
1.31
1.1
2.1
%
146.2
155.0
0.11
15
75
(4094501)
85
675
1.27
1.31
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
45
326
1.39
1.30
2.0
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
65
500
1.31
1.28
3.2
3.0
nmol/l
0.8
0.8
0.03
52
378
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
38
268
1.42
1.27
2.2
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
35
2.29
1.26
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
117
969
1.22
1.25
1.6
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
25
163
1.54
1.23
1.1
1.1
iu/ml
8.8
11.4
—
7
43
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2550
25026
1.09
1.22
4.6
4.4
mmol/l
5.7
5.9
8.79
2370
22757
(4133840)
11
56
1.97
1.22
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
12
64
1.88
1.18
1.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
107
886
1.21
1.16
3.1
3.3
u/ml
462.7
4937.2
0.79
95
742
(3032773) Endomysium IgG Ab [Titer] in Serum
31
215
1.45
1.15
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
31
215
1.45
1.15
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
31
215
1.45
1.15
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
31
215
1.45
1.15
1.6
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
72
1.81
1.15
2.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
23
344
0.67
1.14
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
134
1.57
1.14
2.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
134
1.57
1.14
2.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
134
1.57
1.14
2.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
134
1.57
1.14
2.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
54
413
1.31
1.13
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
17
103
1.65
1.12
1.1
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
263
2938
0.89
1.12
1.7
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
45
336
1.34
1.11
1.5
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
135
1.56
1.11
1.2
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
53
406
1.31
1.11
5.3
3.4
%
1.1
1.4
0.32
38
313
(3017354) Segmented neutrophils/100 leukocytes in Blood
35
251
1.40
1.10
5.9
3.1
%
62.7
55.7
0.92
21
165
(3021901) Oxygen saturation in Capillary blood
55
425
1.30
1.08
4.2
2.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
44
329
1.34
1.08
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
44
329
1.34
1.08
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
222
2500
0.88
1.08
1.5
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
70
560
1.26
1.06
3.5
4.0
kpa
8.8
8.5
0.50
70
551
(3012501) Base excess in Blood by calculation
70
560
1.26
1.06
3.5
4.0
mmol/l
2.1
2.5
0.70
45
383
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
279
1.37
1.05
1.8
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
18
113
1.60
1.05
1.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
137
1.54
1.05
1.2
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
21
137
1.54
1.05
1.2
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
44
331
1.33
1.05
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
44
331
1.33
1.05
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
44
331
1.33
1.05
1.5
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
70
561
1.25
1.05
3.5
4.0
kpa
5.0
5.0
0.40
70
553
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
170
1.47
1.04
1.4
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
22
2.27
1.03
1.8
1.7
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
16
98
1.64
1.03
1.1
1.1
ng/l
34.2
530.7
—
5
24
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
34
2.06
1.03
1.3
2.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
34
2.06
1.03
1.1
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
75
1.74
1.02
1.4
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
33
238
1.39
1.02
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
35
256
1.37
1.00
1.9
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
107
1.59
0.99
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
107
1.59
0.99
1.2
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
24
164
1.47
0.99
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
24
164
1.47
0.99
1.1
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
62
494
1.26
0.99
2.7
2.3
%
15.0
16.3
1.04
33
234
(3052592) Norovirus Ag [Presence] in Stool
9
49
1.84
0.98
1.1
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
112
950
1.19
0.98
5.3
3.9
mmol/l
24.4
24.9
1.29
105
874
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
36
1.95
0.97
3.0
7.9
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
15
92
1.63
0.97
1.3
1.2
%
114.3
109.9
0.40
15
81
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
284
1.34
0.96
2.4
2.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
77
1.69
0.95
1.1
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
327
2993
1.10
0.93
2.1
2.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
28
2.14
0.91
2.3
2.6
u/field
0.3
0.7
—
6
28
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
514
5489
0.92
0.91
4.2
4.4
%
22.2
21.6
0.48
243
2744
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
110
1.55
0.90
1.8
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
110
1.55
0.90
1.8
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
56
697
0.80
0.90
1.3
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
63
1.75
0.90
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
29
2.07
0.89
16.0
11.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
42
1.91
0.88
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
111
1.53
0.87
1.8
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
144
1.46
0.87
2.0
2.9
%
43.9
40.3
—
8
52
(3024932) HLA-DR beta [Type]
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
18
120
1.50
0.85
1.4
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
72
1.67
0.85
1.8
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
46
1.74
0.82
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
52
417
1.25
0.82
1.6
1.4
nmol/l
0.2
0.4
2.41
43
335
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
32
1.88
0.81
1.2
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
32
1.88
0.81
1.2
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
33
1.82
0.79
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
174
1.38
0.76
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
38
483
0.78
0.76
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
54
440
1.23
0.76
1.3
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
59
1.70
0.75
1.7
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
23
166
1.39
0.75
1.2
1.2
mmol/l
32.2
35.8
0.43
23
147
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
67
1.64
0.75
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
197
1782
1.11
0.74
1.2
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
38
1.84
0.73
1.3
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
55
1.64
0.73
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
125
1.44
0.72
1.3
1.8
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
42
335
1.26
0.71
1.7
1.8
—
3.8
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
290
2680
1.09
0.71
2.1
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
17
117
1.46
0.71
1.8
3.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
76
1.58
0.71
1.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
19
134
1.42
0.71
1.8
2.0
ug/min
144.8
144.0
—
6
34
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
41
1.71
0.70
1.6
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
37
292
1.27
0.69
1.2
1.4
pmol/l
248.8
314.3
0.88
30
226
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
77
1.56
0.68
1.0
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
16
110
1.46
0.68
1.0
1.0
u/ml
10.8
9.3
—
5
16
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
23
171
1.35
0.65
1.0
1.0
ng/l
332.0
307.4
0.19
18
106
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
23
171
1.35
0.65
1.0
1.0
ng/l
725.0
678.7
0.25
18
104
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
13
190
0.68
0.65
1.5
1.6
mmol/l
8.1
7.7
—
6
117
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
163
1.35
0.64
1.3
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
348
0.77
0.63
1.4
1.3
mmol/l
6.8
7.4
0.71
17
253
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
104
1.44
0.62
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
16
113
1.42
0.61
5.1
14.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
21
156
1.35
0.61
1.4
1.4
u/l
13.5
13.2
0.06
21
150
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
88
1.48
0.60
3.5
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
284
2646
1.08
0.60
3.1
4.1
ug/l
7.5
18.5
1.95
239
2130
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
80
1.50
0.59
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
80
1.50
0.59
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
97
855
1.14
0.59
2.4
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
24
183
1.31
0.59
1.7
2.1
%
11.2
11.3
0.03
24
183
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
114
1.41
0.58
1.7
1.4
%
3.2
4.9
—
5
25
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
219
1.28
0.58
1.6
1.5
%
31.9
31.4
0.02
20
131
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.2
—
23.8
—
0
23
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
237
1.27
0.58
1.8
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
72
623
1.16
0.57
2.0
2.1
—
—
—
0
0
(4281824)
23
298
0.77
0.57
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
58
493
1.18
0.57
1.2
1.1
u/ml
0.9
1.6
0.73
24
190
(3051387) C reactive protein [Mass/volume] in Capillary blood
47
561
0.84
0.57
4.4
3.3
mg/l
30.4
25.0
0.42
31
367
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
54
1.48
0.57
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
11
161
0.68
0.57
1.6
1.3
mmol/l
5.3
5.8
0.94
11
153
(3010421) pH of Blood
77
671
1.15
0.56
3.6
3.7
ph
7.4
7.4
0.91
70
552
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
73
1.51
0.56
1.0
1.1
—
—
—
0
0
(44813793)
24
185
1.30
0.56
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
97
860
1.13
0.55
2.4
1.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
37
1.62
0.55
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
697
7242
0.95
0.55
1.5
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
17
125
1.36
0.53
4.2
3.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
96
854
1.13
0.53
2.4
1.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
66
1.52
0.52
1.7
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
130
1430
0.91
0.51
1.6
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
145
0.69
0.50
1.2
1.2
—
—
—
0
0
(4024509)
20
258
0.77
0.50
1.4
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
50
426
1.18
0.50
1.1
1.1
u/ml
0.8
1.2
0.40
19
176
(3028707) Methadone [Presence] in Urine by Screen method
45
380
1.19
0.50
2.1
2.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
101
1.39
0.49
1.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
66
576
1.15
0.49
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
78
689
1.14
0.49
1.7
1.9
iu/l
3.5
4.7
1.27
27
249
(44816559) Phosphatidylethanol [Mass/volume] in Blood
54
464
1.17
0.49
1.2
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
18
136
1.33
0.49
1.1
1.2
u/l
740.6
305.9
0.49
18
125
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
45
1.56
0.49
3.6
2.5
—
37.4
—
0
18
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
119
1080
1.11
0.48
2.4
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
46
1.52
0.48
3.1
3.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
76
1.45
0.48
1.8
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
76
1.45
0.48
1.3
1.1
—
—
—
0
0
(4146454)
21
267
0.79
0.47
2.5
2.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
22
173
1.27
0.46
1.0
1.0
ng/l
42.4
44.9
0.12
17
103
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2374
23485
1.04
0.46
5.5
5.5
mmol/mol
38.8
39.4
2.27
2227
21695
(3010726) Horse dander IgE Ab [Units/volume] in Serum
47
402
1.17
0.46
1.1
1.1
u/ml
2.0
1.8
0.05
16
95
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
300
3171
0.94
0.46
4.3
4.4
%
36.4
32.8
6.13
225
2100
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
119
0.67
0.45
2.5
2.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
29
352
0.82
0.45
3.5
5.1
umol/l
453.3
366.3
0.54
22
300
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
51
1.37
0.44
1.9
2.2
umol/l
12.0
17.0
—
7
51
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
95
1.37
0.43
2.7
2.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
148
1.29
0.43
1.4
1.5
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
5
31
1.61
0.43
1.2
1.0
u/ml
—
0.2
—
0
19
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
239
1.22
0.42
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
108
985
1.10
0.42
2.3
1.8
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
34
402
0.84
0.41
1.1
1.1
iu/ml
7.7
1442.9
—
6
93
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
38
324
1.17
0.40
1.1
1.1
u/ml
2.6
4.2
0.86
17
124
(3038177) Helicobacter pylori Ab [Presence] in Serum
47
408
1.15
0.40
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
141
1.28
0.40
1.3
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
168
1.25
0.40
1.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
5.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
264
2501
1.06
0.39
1.5
1.6
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
19
0.00
0.39
0.0
1.6
—
13.8
—
0
11
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
43
372
1.16
0.38
1.1
1.1
u/ml
1.2
2.2
—
8
162
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
115
0.69
0.37
1.3
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
93
849
1.10
0.37
2.4
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
49
556
0.88
0.36
1.9
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
61
544
1.12
0.36
3.4
3.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
70
1.29
0.36
1.3
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
73
659
1.11
0.36
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
87
793
1.10
0.36
2.6
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
56
628
0.89
0.35
1.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
122
0.74
0.35
1.1
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
82
747
1.10
0.34
1.5
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2389
23688
1.03
0.34
20.8
14.2
%
38.9
39.4
1.96
1689
16994
(3024263) Appearance of Synovial fluid
17
136
1.25
0.33
1.4
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
140
1311
1.07
0.32
3.3
3.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
77
840
0.91
0.31
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
26
221
1.18
0.30
1.1
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
54
1.30
0.30
1.4
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
55
1.27
0.30
1.7
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
107
0.75
0.29
1.0
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
59
535
1.10
0.29
3.3
3.3
u/ml
163.3
808.6
0.73
49
493
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
49
441
1.11
0.27
1.1
1.1
u/ml
3.7
5.7
0.44
24
220
(3012516) Albumin [Mass/volume] in Urine
739
7229
1.03
0.27
3.4
3.2
mg/l
1671.3
337.7
3.31
471
4483
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
113
1.24
0.26
1.8
2.4
umol/l
45.4
51.6
—
8
89
(44806420)
5
74
0.68
0.26
1.8
2.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
72
1.25
0.25
1.1
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
34
383
0.89
0.25
1.7
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
216
1.16
0.25
1.8
2.1
u/field
2.9
1.9
0.39
13
85
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
33
292
1.13
0.25
1.2
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
75
1.20
0.25
1.6
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
76
1.18
0.24
1.8
2.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
76
1.18
0.24
3.9
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
17
142
1.20
0.24
1.5
1.4
umol/l
26.6
25.6
0.04
17
134
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
77
1.17
0.24
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
150
1427
1.05
0.23
1.7
1.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
13
158
0.82
0.23
2.2
2.1
ug/l
2.2
3.3
0.47
13
138
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
3.1
umol/l
54.2
41.1
—
5
30
(1001926) Buprenorphine [Presence] in Urine by Screen method
72
669
1.08
0.23
2.7
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
39
1.28
0.23
4.2
6.0
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
15
125
1.20
0.22
1.1
1.1
u/l
75.1
79.3
0.11
15
94
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
15
125
1.20
0.22
1.1
1.1
u/l
11.8
23.0
1.20
15
92
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
79
1.27
0.22
1.0
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
14
116
1.21
0.22
1.9
3.0
ph
7.4
7.4
—
7
39
(3011288) Drugs identified in Urine by Screen method
65
603
1.08
0.22
3.2
2.6
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
15.0
—
0
10
(3041672) Baker's yeast Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
10
0.00
0.21
0.0
4.9
—
185.4
—
0
5
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
2.4
—
0
12
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
27.0
—
0
5
(3020682) Albumin/Creatinine [Ratio] in Urine
771
7589
1.02
0.19
3.9
4.0
mg/mmol
13.0
7.8
1.50
483
4719
(3004451) EKG impression Narrative
14
118
1.19
0.19
1.5
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
58
1.21
0.18
2.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
673
6841
0.98
0.18
4.4
5.1
ug/l
2.3
3.7
1.38
597
6084
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
142
0.84
0.17
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
39
359
1.09
0.16
1.1
1.1
u/ml
5.2
2.5
0.37
21
129
(3009508) Creatinine [Moles/volume] in Urine
786
7751
1.02
0.16
3.2
3.1
mmol/l
6.8
7.4
3.34
693
6519
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
183
0.87
0.16
1.4
1.5
g/l
0.9
0.9
0.49
16
183
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2527
25168
1.02
0.16
4.5
4.2
mmol/l
1.6
1.5
9.67
2376
23157
(1761482) Bacteria [#/volume] in Urine by Culture
60
637
0.94
0.15
4.0
4.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
161
0.87
0.15
1.6
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
159
1.13
0.15
1.1
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
17
150
1.13
0.14
1.0
1.0
u/ml
8.9
0.8
—
10
53
(3036071) Salmonella sp Ab [Titer] in Serum
10
84
1.19
0.14
1.5
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
110
0.82
0.13
1.8
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
179
0.89
0.12
4.0
6.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
69
659
1.05
0.12
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
144
1398
1.03
0.12
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2431
24234
1.01
0.11
4.1
3.8
mmol/l
1.2
1.3
9.63
2277
22143
(3000034) Microalbumin [Mass/volume] in Urine
20
218
0.92
0.10
2.0
3.1
mg/l
18.8
31.2
0.55
14
158
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
32
300
1.07
0.10
1.0
1.0
u/ml
0.1
0.2
—
8
71
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
184
1.09
0.09
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
126
1.11
0.09
3.4
3.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
58
1.03
0.08
3.2
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
65
0.77
0.08
1.4
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
65
0.77
0.08
1.4
2.9
—
—
—
0
0
(4198724)
10
88
1.14
0.08
1.2
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
7
66
1.06
0.08
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
339
3432
0.99
0.07
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2541
25356
1.01
0.07
4.6
4.2
mmol/l
4.6
4.7
6.38
2398
23462
(3040151) Glucose [Moles/volume] in Capillary blood
28
264
1.06
0.07
3.5
5.5
mmol/l
6.0
7.5
3.72
23
221
(3000963) Hemoglobin [Mass/volume] in Blood
2885
28891
0.99
0.07
29.1
19.8
g/l
132.7
134.4
9.00
2859
28459
(3035941) MCH [Entitic mass]
2884
28881
0.99
0.07
28.8
19.6
pg
30.4
30.3
3.51
2860
28444
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
9
84
1.07
0.07
3.8
2.7
umol/l
26.2
28.4
—
9
56
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
95
0.84
0.06
1.3
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
47
488
0.96
0.06
4.8
2.9
mmol/l
7.7
7.4
0.29
47
477
(3010813) Leukocytes [#/volume] in Blood
2885
28887
0.99
0.06
29.0
19.7
e9/l
6.6
6.7
2.42
2828
28051
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
101
0.89
0.06
1.9
1.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
21
223
0.94
0.06
1.1
1.4
mmol/l
9.4
12.6
—
7
55
(3026361) Erythrocytes [#/volume] in Blood
2885
28882
0.99
0.05
29.0
19.7
e12/l
4.4
4.5
12.93
2829
28050
(3024731) MCV [Entitic volume]
2885
28878
0.99
0.04
28.9
19.6
fl
91.7
91.0
12.72
2862
28443
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
102
1035
0.99
0.03
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
24
230
1.04
0.03
1.4
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
151
1526
0.99
0.03
2.8
3.4
u/ml
33.5
54.0
1.51
146
1478
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
182
1804
1.01
0.03
1.8
1.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
201
1.05
0.03
1.3
1.2
u/ml
0.4
1.0
0.48
12
86
(1002224) Polysomnography panel
97
983
0.99
0.03
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
192
1.04
0.02
1.6
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2885
28865
1.00
0.02
28.9
19.7
e9/l
255.1
253.4
0.74
2834
28109
(3008037) Lactate [Moles/volume] in Venous blood
51
519
0.98
0.02
4.6
2.8
mmol/l
1.6
1.5
0.12
51
506
(3044242) Glucose [Moles/volume] in Arterial blood
13
123
1.06
0.01
1.5
2.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
153
1.05
0.01
1.4
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2582
25832
1.00
0.01
5.1
4.7
mmol/l
2.6
2.8
15.86
2434
23762
(3003740) Influenza virus B Ag [Presence] in Specimen
39
397
0.98
0.01
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
39
397
0.98
0.01
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
156
0.96
0.00
1.2
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
279
1.00
0.00
2.5
2.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
132
0.98
0.00
1.4
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
56
564
0.99
0.00
1.9
2.3
ug/min
125.4
89.9
0.36
37
339
(3045142) Bone marrow Pathology biopsy report
27
267
1.01
0.00
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
133
0.98
0.00
1.4
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
57
0.88
0.00
1.0
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
69
1.01
0.00
1.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
73
0.96
0.00
1.0
1.8
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.8
—
0
6
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
171.0
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
5
55
0.91
0.00
2.4
2.0
—
—
—
0
0
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
30.8
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
392.6
—
0
5
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
6.5
—
0
8
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
33
330
1.00
0.00
1.5
1.4
ug/l
2.8
3.2
0.21
28
290
(3034614) HLA Ag [Interpretation]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
115.1
—
0
6
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
45.2
—
0
5
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
14
140
1.00
0.00
3.4
3.5
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
9
0.00
-0.00
0.0
1.7
—
1.2
—
0
9
(3013862) HLA-DP [Type]
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_OTHPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_OTHPER | 1.7 [1.52, 1.91] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 1192 out of 7354 females with I9_OTHPER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_OTHPER | 1.81 [1.64, 2.0] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.127 |
During the follow-up period (1.1.1998 — 31.12.2019), 1800 out of 5294 males with I9_OTHPER died.
Mortality risk
Mortality risk for people of age
years, who have I9_OTHPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.137% | 0.308% |
| 5 | 0.916% | 2.373% |
| 10 | 2.318% | 6.072% |
| 15 | 4.252% | 11.376% |
| 20 | 7.267% | 19.122% |
Relationships between endpoints
↥Index endpoint: I9_OTHPER – Other peripheral vascular diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data